Basophil Activation and Histamine Release Tests in Relation to Omalizumab Response in Peanut‐Allergic Children

Documenti analoghi

• Hypersensitivity to Biologics Used in the Treatment of Inflammatory Disorders: Allergy Interventions and Outcomes
  di: Trine Holm Rasmussen, et al.
  Pubblicazione: (2026)
• Impact of Co‐Factors in Primary Hazelnut Allergy
  di: Morten J. Christensen, et al.
  Pubblicazione: (2024)
• Children Allergic to Peanut and/or Tree Nuts Are at Risk of Accidental Allergic Reactions
  di: Marina Vasse, et al.
  Pubblicazione: (2025)
• Basophil Activation Test for the In Vitro Diagnosis of Tocilizumab Hypersensitivity
  di: Ana Koren, et al.
  Pubblicazione: (2026)
• One Year of Oral Immunotherapy Impacts the Gut Microbiota and Plasma Metabolome of Peanut‐Allergic Young Children
  di: Isabella Badolati, et al.
  Pubblicazione: (2024)